These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15793532)

  • 21. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
    Lee CH; Mamelak AJ; Vonderheid EC
    Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The therapeutic potential of extracorporeal photopheresis.
    Girardi M
    Clin Adv Hematol Oncol; 2006 May; 4(5):349-50. PubMed ID: 16728944
    [No Abstract]   [Full Text] [Related]  

  • 23. [Extracorporeal photopheresis].
    Prinz B; Plewig G
    Hautarzt; 1994 Nov; 45(11):746-50. PubMed ID: 7822197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of extracorporeal photopheresis on cytokines released by leukaemic cutaneous T-cell lymphoma.
    Br J Dermatol; 2023 Oct; 189(5):e97. PubMed ID: 37879744
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma.
    Tran J; Morris L; Vu A; Reddy S; Duvic M
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photopheresis for the treatment of cutaneous T cell lymphoma.
    Armus S; Keyes B; Cahill C; Berger C; Crater D; Scarborough D; Klainer A; Bisaccia E
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):898-902. PubMed ID: 2147701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of offline extracorporeal photopheresis in cutaneous T-cell lymphomas: A retrospective study.
    Moreno-Vílchez C; Muniesa C; González-Barca E; García-Muñoz N; Ortega-Sánchez S; Servitje O
    Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):667-669. PubMed ID: 37465951
    [No Abstract]   [Full Text] [Related]  

  • 28. [Extracorporeal photopheresis--a new therapeutic concept].
    Trattner A; David M
    Harefuah; 1993 Nov; 125(10):368-70. PubMed ID: 8253407
    [No Abstract]   [Full Text] [Related]  

  • 29. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?
    Rao V; Ryggen K; Aarhaug M; Dai HY; Jørstad S; Moen T
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1100-7. PubMed ID: 16987266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes.
    Zouboulis CC; Schmuth M; Doepfmer S; Dippel E; Orfanos CE
    Dermatology; 1998; 196(3):305-8. PubMed ID: 9621137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythrodermic CTCL: a case study of treatment with extracorporeal photopheresis.
    McCann SA; Smith SG
    Dermatol Nurs; 2000 Apr; 12(2):103-8, 111-2. PubMed ID: 11271057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive squamous cell carcinoma with sporotrichoid metastasis in a patient with cutaneous T cell lymphoma treated with chronic extracorporeal photopheresis.
    Gmyrek R; Beer R; Elizeri Y; Oster MW; Silvers DN; Schneiderman P; Grossman ME
    Cutis; 1999 Oct; 64(4):261-4. PubMed ID: 10544882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection.
    Wolfe JT; Lessin SR; Singh AH; Rook AH
    Artif Organs; 1994 Dec; 18(12):888-97. PubMed ID: 7887825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of extracorporeal photopheresis in a diverse cohort of patients with cutaneous T-cell lymphoma: a retrospective study at a tertiary care hospital.
    Weiner DM; Kumar P; Varadhan R; Sweren R; Kim N; Rozati S
    J Dermatolog Treat; 2024 Dec; 35(1):2312250. PubMed ID: 38331434
    [No Abstract]   [Full Text] [Related]  

  • 35. [Photopheresis].
    Ortiz-Romero PL
    Actas Dermosifiliogr; 2009; 100(6):443-4. PubMed ID: 19709547
    [No Abstract]   [Full Text] [Related]  

  • 36. Extracorporeal photopheresis as a treatment for patients with cutaneous T-cell lymphoma: real-world data at a reference cancer centre in Colombia.
    Toquica A; Enciso-Olivera L; Rueda-Lozada X
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e780-e781. PubMed ID: 35596720
    [No Abstract]   [Full Text] [Related]  

  • 37. Extracorporeal photopheresis: Lighting the way to immunomodulation.
    Babic AM
    Am J Hematol; 2008 Jul; 83(7):589-91. PubMed ID: 18335565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is cutaneous T-cell lymphoma curable?
    Koh HK; Jacobson JO; Foss F; Lew RA
    Arch Dermatol; 1995 Sep; 131(9):1081-2. PubMed ID: 7661616
    [No Abstract]   [Full Text] [Related]  

  • 39. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corynebacterium jeikeium sepsis after 8-methoxypsolaren photopheresis for cutaneous T-cell lymphoma.
    Umeh OC; Kubak BM; Pegues DA; Leibowitz MR; Froch L
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):71-2. PubMed ID: 15380280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.